The MarketWatch News Department was not involved in the creation of this content. Results presented in oral session demonstrated that treatment with ataciguat reduced aortic valve calcium and improved ...

Please provide your email address to receive an email when new articles are posted on . TAVR did not improve a composite of clinical endpoints in patients with moderate aortic stenosis and HFrEF.

Many people around the age of 60 experience a decline in physical performance due to aortic valve stenosis. In this condition, the heart valve, which is located between the left ventricle and the ...

Lipoprotein(a) is not associated with active calcification of the aortic valve in patients with mild-to-moderate aortic stenosis, according to a study presented this week at the European ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with acute heart attack and moderate aortic ...

Mechanisms of heart-valve disease often mimic processes observed in embryonic and early childhood development, including activation of valvular interstitial cell (VIC) phenotypes and remodeling of ...

A sizeable proportion of patients diagnosed with moderate aortic stenosis (AS) will have hemodynamic parameters on echocardiography that don’t match the standard definition, and many may be at greater ...

Aortic stenosis is a disease often diagnosed in its asymptomatic phase due to its distinct murmur and the widespread use of noninvasive imaging. The history, however, is still of paramount importance ...

Kardigan Presents Positive Phase 2 Data on Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis at American Heart Association Scientific Sessions 2025 Results presented in oral session ...

Results presented in oral session demonstrated that treatment with ataciguat reduced aortic valve calcium and improved cardiac function and output compared to placebo SOUTH SAN FRANCISCO, Calif. & ...